For the first five months of this year, revenues from sales decreased by 13% compared to the same period of 2015, including 3% decrease of domestic sales and a 19% decrease of export sales, which is due to the lower number of workdays in the month of May.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that for April 2016 Sopharma AD realized a decrease of sales revenues of 19% compared to the same month of last year, including retention of the level of domestic sales and 29% decrease of export sales.